Remove Books Remove Licensing Remove Vaccine
article thumbnail

Addressing the grand challenge of global access to vaccines

Drug Target Review

The mad scramble 1 for -80°C freezers during the COVID-19 pandemic is a vivid illustration that we remain unprepared to harness the global potential of vaccine therapeutics. 2 However, it is not just problematic cold chains that limit access to life-saving vaccines. Development was also fuelled by an avalanche 10 of public funding.

Vaccine 96
article thumbnail

Dr. Kent R. Van Kampen Celebrated for Dedication to the Field of Pharmaceutical Research

The Pharma Data

Van Kampen excels as the chief executive officer of The Van Kampen Group, which assists other companies in research and liaisons with government and industry regarding licensing products for commercial use. Van Kampen worked as chief operating officer and chief executive officer of Vaxin, Inc.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Page 1

The Pharma Data

The information in this e-book will change how you treat your shoulder forever and is guaranteed to improve your health and quality of life for years to come. This e-book contains a proven self workout plan for ending your rotator cuff pain that has been endorsed & approved by orthopedic physicians. . personalfitnessadvantage.com.

article thumbnail

Coronavirus: Avoid 'party weekend' ahead of new restrictions, public told

The Pharma Data

“There is an anticipation that everyone is going to have a big last binge, but people are starting to get fearful and a lot of licensed premises have already been clamped down on by the police,” he said. How close to developing a vaccine are we? But some have now reported being unable to book a swab at all.

Virus 52
article thumbnail

The Chronic Fatigue Syndrome Solution™ – Free Yourself From CFS, Naturally!

The Pharma Data

Once you’ve downloaded your book, read the entire guide and start immediately! This book will guide you step-by-step, and it is extremely easy to follow. other licensed healthcare provider. You will be able to learn the secrets of treating your Chronic Fatigue Syndrome, in just minutes from now.

Doctors 52
article thumbnail

U.S. FDA ACCEPTS FOR PRIORITY REVIEW

The Pharma Data

FDA ACCEPTS FOR PRIORITY REVIEW PFIZER’S APPLICATION FOR TICOVAC (TICK-BORNE ENCEPHALITIS VACCINE). If approved, the vaccine may help reduce the risk of TBE for people traveling to endemic areas, potentially including military personnel serving in these locations. 1,2 If approved, TicoVac would be the first vaccine in the U.S.

FDA 52
article thumbnail

Sanofi delivered close to double-digit Q4 2020

The Pharma Data

Vaccines up 14.6%, driven by record demand for differentiated influenza vaccines and continued growth of PPH. to €36,041 million, driven by Dupixent ® (€3,534 million, up 73,9%) and Vaccines. We continue to work in parallel on our two COVID-19 vaccine candidates, with clinical trials starting in the coming weeks.

Vaccine 52